A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy
Clinical trial NCT04641962 · TERMINATED
Trial details
- NCT number
- NCT04641962
- Sponsor
- Astellas Pharma Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-24
- Primary completion
- 2024-05-08
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.